Insulet Corporation combines high gross and operating margins with positive revenue, earnings, and free cash flow growth, but trades at elevated valuation multiples and a low free cash flow yield. The share price is under pressure over 1–6 months and trading below key moving averages near the lower end of its 52-week range, even as some short-term technical signals show early signs of momentum stabilization. Balance sheet liquidity appears comfortable relative to near-term obligations, while meaningful long-term debt and rich pricing frame the main risk considerations.